SKIN Beauty Health Co
Price (delayed)
$0.8213
Market cap
$102.86M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.23
Enterprise value
$300.96M
BeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Its flagship brand, HydraFacial, is a non-invasive and approachable beauty health platform and ecosystem with a
Highlights
Beauty Health's EPS has soared by 70% YoY and by 4.2% from the previous quarter
SKIN's gross margin is up by 40% YoY and by 8% from the previous quarter
The net income has surged by 71% year-on-year but it has declined by 3.3% since the previous quarter
The revenue has decreased by 16% YoY and by 3.8% from the previous quarter
The company's equity fell by 13% QoQ and by 13% YoY
Key stats
What are the main financial stats of SKIN
Market
Valuations
Earnings
Shares outstanding
125.25M
Market cap
$102.86M
Enterprise value
$300.96M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.97
Price to sales (P/S)
0.3
EV/EBIT
N/A
EV/EBITDA
20.7
EV/Sales
0.9
Revenue
$334.29M
Gross profit
$182.3M
Operating income
-$67.77M
Net income
-$29.1M
EBIT
-$19.14M
EBITDA
$14.54M
Free cash flow
$9.34M
Per share
Balance sheet
Liquidity
EPS
-$0.23
EPS diluted
-$0.36
Free cash flow per share
$0.08
Book value per share
$0.42
Revenue per share
$2.7
TBVPS
$4.16
Total assets
$685.68M
Total liabilities
$633.88M
Debt
$568.16M
Equity
$51.8M
Working capital
$408.97M
Debt to equity
10.97
Current ratio
7
Quick ratio
5.84
Net debt/EBITDA
13.62
Margins
Efficiency
Dividend
EBITDA margin
4.4%
Gross margin
54.5%
Net margin
-8.7%
Operating margin
-20.3%
Return on assets
-4%
Return on equity
-47.7%
Return on invested capital
-2.7%
Return on capital employed
-3.1%
Return on sales
-5.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SKIN stock price
How has the Beauty Health stock price performed over time
Intraday
-2.9%
1 week
-17.87%
1 month
-37.31%
1 year
-74.88%
YTD
-48.35%
QTD
-38.71%
Financial performance
How have Beauty Health's revenue and profit performed over time
Revenue
$334.29M
Gross profit
$182.3M
Operating income
-$67.77M
Net income
-$29.1M
Gross margin
54.5%
Net margin
-8.7%
The net income has surged by 71% year-on-year but it has declined by 3.3% since the previous quarter
SKIN's net margin has soared by 65% year-on-year but it is down by 7% since the previous quarter
The operating income has grown by 48% year-on-year and by 14% since the previous quarter
SKIN's gross margin is up by 40% YoY and by 8% from the previous quarter
Growth
What is Beauty Health's growth rate over time
Valuation
What is Beauty Health stock price valuation
P/E
N/A
P/B
1.97
P/S
0.3
EV/EBIT
N/A
EV/EBITDA
20.7
EV/Sales
0.9
Beauty Health's EPS has soared by 70% YoY and by 4.2% from the previous quarter
The P/B is 57% below the last 4 quarters average of 4.7
The company's equity fell by 13% QoQ and by 13% YoY
The P/S is 93% less than the 5-year quarterly average of 4.5 and 61% less than the last 4 quarters average of 0.8
The revenue has decreased by 16% YoY and by 3.8% from the previous quarter
Efficiency
How efficient is Beauty Health business performance
Beauty Health's ROS has soared by 74% YoY but it has decreased by 30% from the previous quarter
The ROIC has soared by 72% YoY but it has contracted by 35% from the previous quarter
The ROA has soared by 61% YoY but it has contracted by 14% from the previous quarter
The company's return on equity rose by 45% YoY but it fell by 6% QoQ
Dividends
What is SKIN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SKIN.
Financial health
How did Beauty Health financials performed over time
Beauty Health's total assets is 8% higher than its total liabilities
The total liabilities has contracted by 27% YoY
Beauty Health's total assets has decreased by 26% YoY
SKIN's debt is down by 24% year-on-year
SKIN's debt to equity is up by 15% since the previous quarter but it is down by 13% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.